Skip to main content
. 2019 Dec 23;7:342. doi: 10.3389/fcell.2019.00342

FIGURE 5.

FIGURE 5

lncRNA MEG3 targets miR-128-3p in neurogenic differentiation from AECs. (A) The expression of MEG3 was analyzed in normal and induced AECs using RT-qPCR. (B) The binding site between MEG3 and miR-128-3p was predicted using bioinformatics algorithms and subsequently mutated to verify interactions. (C) Full-length MEG3 (WT) and sequences containing different mutated variants of the miR-128-3p binding site (MUT) were tested to determine the effect on miR-15/16 expression. The pRL-40 vector alone was used as an internal control. Results are expressed as relative luciferase activity and represent the mean ± SD of at least three replicates. (D) Immunoprecipitation of Myc-tagged Argonaute 2 (AGO2) from AECs co-transfected with Myc-AGO2 and either miR-128-3p or Let-7a (negative control). Empty vector (EV) served as the Myc-AGO2-related negative control. MEG3 and β-actin mRNA levels were quantified using qPCR, and relative immunoprecipitate (IP)/input (cell total RNA) values were plotted. P < 0.05; ∗∗P < 0.01.